Expression of PRDM10 in arthritic synovial derived tissues

Jin Ah Park, Tae-Hwan Kim, Bitnara Lee, Eunji Kwon, Keun Cheol Kim

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

We previously reported the expression of PRDM10 in skeletal cartilage during mouse embryonic development. In this study, we examined PRDM10 expression in blood, synovial fluid and synovium from patients with rheumatoid arthritis (RA) or osteoarthritis (OA). PRDM10 mRNA was detected in all peripheral blood and RA synovial fluid, as well as in normal blood. We also performed immunohistochemistry with human synovium tissues. Compared to other PR/SET proteins including PRDM14, PRDM12, and SUV39H1, PRDM10 expression was conspicuous in cells of the synovial lining layer, subintimal layer, and perivascular layer in RA and OA synovium. Immunostaining using cultured fibroblast like synoviocytes detected PRDM10 mainly in the nucleus, with a small amount detected in the cytoplasm. Transforming growth factor-beta (TGF-β) treatment decreased PRDM10 expression in OA-derived FLS cells, whereas polyinosinic:polycytidylic acid or lipopolysaccharide treatment did not produce a distinct change of PRDM10 expression, PRDM10 expression was reversed by the smad inhibitor SB431542. Given that PRDM10 is highly expressed in human synovial tissues and is transcriptionally regulated by TGF-β, we suggest that PRDM10 might be involved in the pathogenesis of arthritis.

Original languageEnglish
Pages (from-to)685-691
Number of pages7
JournalGenes and Genomics
Volume35
Issue number6
DOIs
StatePublished - 2013 Dec 1

Fingerprint

Synovial Membrane
Osteoarthritis
Arthritis
Rheumatoid Arthritis
Blood
Synovial Fluid
Tissue
Transforming Growth Factor beta
Poly I-C
Fluids
Cartilage
Fibroblasts
Linings
Embryonic Development
Lipopolysaccharides
Cytoplasm
Immunohistochemistry
Messenger RNA
Therapeutics
Proteins

Keywords

  • Arthritis
  • Expression
  • PRDM10
  • Synovial fluid
  • Synovium

Cite this

Park, Jin Ah ; Kim, Tae-Hwan ; Lee, Bitnara ; Kwon, Eunji ; Kim, Keun Cheol. / Expression of PRDM10 in arthritic synovial derived tissues. In: Genes and Genomics. 2013 ; Vol. 35, No. 6. pp. 685-691.
@article{bc3be72dface41d98a0addebc8ee6a1d,
title = "Expression of PRDM10 in arthritic synovial derived tissues",
abstract = "We previously reported the expression of PRDM10 in skeletal cartilage during mouse embryonic development. In this study, we examined PRDM10 expression in blood, synovial fluid and synovium from patients with rheumatoid arthritis (RA) or osteoarthritis (OA). PRDM10 mRNA was detected in all peripheral blood and RA synovial fluid, as well as in normal blood. We also performed immunohistochemistry with human synovium tissues. Compared to other PR/SET proteins including PRDM14, PRDM12, and SUV39H1, PRDM10 expression was conspicuous in cells of the synovial lining layer, subintimal layer, and perivascular layer in RA and OA synovium. Immunostaining using cultured fibroblast like synoviocytes detected PRDM10 mainly in the nucleus, with a small amount detected in the cytoplasm. Transforming growth factor-beta (TGF-β) treatment decreased PRDM10 expression in OA-derived FLS cells, whereas polyinosinic:polycytidylic acid or lipopolysaccharide treatment did not produce a distinct change of PRDM10 expression, PRDM10 expression was reversed by the smad inhibitor SB431542. Given that PRDM10 is highly expressed in human synovial tissues and is transcriptionally regulated by TGF-β, we suggest that PRDM10 might be involved in the pathogenesis of arthritis.",
keywords = "Arthritis, Expression, PRDM10, Synovial fluid, Synovium",
author = "Park, {Jin Ah} and Tae-Hwan Kim and Bitnara Lee and Eunji Kwon and Kim, {Keun Cheol}",
year = "2013",
month = "12",
day = "1",
doi = "10.1007/s13258-013-0119-z",
language = "English",
volume = "35",
pages = "685--691",
journal = "Genes and Genomics",
issn = "1976-9571",
number = "6",

}

Expression of PRDM10 in arthritic synovial derived tissues. / Park, Jin Ah; Kim, Tae-Hwan; Lee, Bitnara; Kwon, Eunji; Kim, Keun Cheol.

In: Genes and Genomics, Vol. 35, No. 6, 01.12.2013, p. 685-691.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Expression of PRDM10 in arthritic synovial derived tissues

AU - Park, Jin Ah

AU - Kim, Tae-Hwan

AU - Lee, Bitnara

AU - Kwon, Eunji

AU - Kim, Keun Cheol

PY - 2013/12/1

Y1 - 2013/12/1

N2 - We previously reported the expression of PRDM10 in skeletal cartilage during mouse embryonic development. In this study, we examined PRDM10 expression in blood, synovial fluid and synovium from patients with rheumatoid arthritis (RA) or osteoarthritis (OA). PRDM10 mRNA was detected in all peripheral blood and RA synovial fluid, as well as in normal blood. We also performed immunohistochemistry with human synovium tissues. Compared to other PR/SET proteins including PRDM14, PRDM12, and SUV39H1, PRDM10 expression was conspicuous in cells of the synovial lining layer, subintimal layer, and perivascular layer in RA and OA synovium. Immunostaining using cultured fibroblast like synoviocytes detected PRDM10 mainly in the nucleus, with a small amount detected in the cytoplasm. Transforming growth factor-beta (TGF-β) treatment decreased PRDM10 expression in OA-derived FLS cells, whereas polyinosinic:polycytidylic acid or lipopolysaccharide treatment did not produce a distinct change of PRDM10 expression, PRDM10 expression was reversed by the smad inhibitor SB431542. Given that PRDM10 is highly expressed in human synovial tissues and is transcriptionally regulated by TGF-β, we suggest that PRDM10 might be involved in the pathogenesis of arthritis.

AB - We previously reported the expression of PRDM10 in skeletal cartilage during mouse embryonic development. In this study, we examined PRDM10 expression in blood, synovial fluid and synovium from patients with rheumatoid arthritis (RA) or osteoarthritis (OA). PRDM10 mRNA was detected in all peripheral blood and RA synovial fluid, as well as in normal blood. We also performed immunohistochemistry with human synovium tissues. Compared to other PR/SET proteins including PRDM14, PRDM12, and SUV39H1, PRDM10 expression was conspicuous in cells of the synovial lining layer, subintimal layer, and perivascular layer in RA and OA synovium. Immunostaining using cultured fibroblast like synoviocytes detected PRDM10 mainly in the nucleus, with a small amount detected in the cytoplasm. Transforming growth factor-beta (TGF-β) treatment decreased PRDM10 expression in OA-derived FLS cells, whereas polyinosinic:polycytidylic acid or lipopolysaccharide treatment did not produce a distinct change of PRDM10 expression, PRDM10 expression was reversed by the smad inhibitor SB431542. Given that PRDM10 is highly expressed in human synovial tissues and is transcriptionally regulated by TGF-β, we suggest that PRDM10 might be involved in the pathogenesis of arthritis.

KW - Arthritis

KW - Expression

KW - PRDM10

KW - Synovial fluid

KW - Synovium

UR - http://www.scopus.com/inward/record.url?scp=84891004132&partnerID=8YFLogxK

U2 - 10.1007/s13258-013-0119-z

DO - 10.1007/s13258-013-0119-z

M3 - Article

AN - SCOPUS:84891004132

VL - 35

SP - 685

EP - 691

JO - Genes and Genomics

JF - Genes and Genomics

SN - 1976-9571

IS - 6

ER -